Articles 7 Questions: Jörg Land on the first reimbursed mobile app in... Jörg Land talks about the approval process for a new app technology for treating tinnitus, the first ever to be reimbursed in Germany
News Beacon's XLRP gene therapy set for filing after phase 3 win Beacon is preparing to file for approval of its gene therapy for X-linked retinitis pigmentosa, after reporting encouraging phase 3 data.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.